FDA's Makary expects decision on Prasad successor in coming weeks
Tweet
Share
E-mail
FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo
By Ahmed Aboulenein and Puyaan Singh
WASHINGTON, April 28 (Reuters) - U.S. Food and Drug Administration Commissioner Marty Makary said on Tuesday there had been no decision yet on outgoing vaccine chief Vinay Prasad's replacement but that he expects an announcement over the coming weeks.
The FDA announced Prasad's departure as director of its Center for Biologics Evaluation and Research last month. Makary at the time said Prasad would leave by the end of April and that a successor would be named by then.
• "The search for the director of the biologic center is going extremely well. We have terrific candidates that so that process is going well," said Makary.
• "No decision has been reached at this point, but I expect it in the coming weeks," he added.
• Prasad, an oncologist, was an outspoken critic of U.S. drug and vaccine policies, particularly around COVID-19 mandates, before joining the agency.
(Reporting by Ahmed Aboulenein in Washington and Puyaan Singh in Bengaluru; Additional reporting by Padmanabhan Ananthan in Bengaluru; Editing by Tasim Zahid and Edward Tobin)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
- US appeals court throws out California, Giffords 'ghost guns' challenge
- US judge strikes down policy suspending immigrant visa processing for 75 nations
Create E-mail Alert Related Categories
ReutersRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
